This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to look into a large and sudden spike in synthetic cannabinoid use/overdoses in a particular community); 2) responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and time-sensitive prescription drug abuse research opportunities (e.g.,new state or local efforts); 4) responses to unexpected and time-sensitive medical system issues (e.g. opportunities to understand addiction services in the evolving health care system); and 5) responses to unexpected and time-sensitive criminal or juvenile justice opportunities (e.g. new system and/or structural level changes) that relate to drug abuse and access and provision of health care service. It should be clear that the knowledge gained from the proposed study is time-sensitive and that an expedited rapid review and funding are required in order for the scientific question to be answered.
The first Health and Human Performance Research (HHPR) Summit is upcoming April 28-30, 2015 in Dayton, Ohio. We are on target to have more than 200 attendees, 75+ posters, and 12 breakout sessions discussing the topics of the summit. More than 75 participants from Federal Research labs will be presenting and participating in the event and it is a great opportunity for our Ohio Academic Institutions to create relationships and understand the objectives of these researchers. As such, we have an interest in ensuring Ohio universities and research institutions are represented in this event to increase the funding which is attracted to our State. We would like to extend an invitation to your institution to participate in the Summit through poster presentations and/or attending the Summit. Designed to provide networking opportunities for researchers and industry to connect through a focus on exploring commercializing opportunities in Science and Technology within the health and human performance domain; the HHPR Summit is also intended to further develop the research relationships with the Air Force Research Laboratory (AFRL) and support the commercialization within Ohio. It is important to us as we look to the strategies we are undertaking as a state to ensure the major universities and research institutions have an opportunity to play a major role in this relationship. Details of the Summit follows:
The HHPR Summit is an international meeting supporting human systems research held at the Dayton Convention Center in Dayton, Ohio April 28-30, 2015 with the objective of linking defense and academic research to the commercial domains. The Summit is a forum to generate research knowledge and ideas, recruit and retain key organizations and researchers in the human systems domain, and link research to entrepreneurial outcomes, and diffuse information.
This Funding Opportunity Announcement (FOA) invites grant applications from institutions/organizations that propose to build research infrastructure to promote external collaboration with the medical rehabilitation community. The aim of this FOA is to create a national network of research cores that provide access to collateral expertise in biomedical, behavioral, engineering, and/or psychosocial fields that is particularly relevant to medical rehabilitation research. We are particularly interested in supporting infrastructure programs in clinical trial design, engineering and the environment, individualized medical rehabilitation and dynamic reassessment, and applied behavioral supports for rehabilitation research and healthy outcomes. However, other areas of expertise may be proposed provided they offer unique research opportunities and have potential for promoting medical rehabilitation research and improving outcomes for people with disabilities. In response to this FOA, applicants should propose a program of research resources and collaborative opportunities in a specific research domain. This may be accomplished through a workshops, written material, and websites, consultations, collaborations, and pilot funding. In addition, the research core may support activities within the grantee institution related to technique development, adaptation, and validation. To accomplish the aims of the FOA, applicants may propose collaborations to other institutional sites, provided that they cover the appropriate administrative and logistical issues.
This Funding Opportunity Announcement (FOA) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes in an effort to prevent or reduce obesity. This FOA is intended to support research where opportunities for empirical study are, by their very nature, only available through expedited review and funding. All applications to this FOA must demonstrate that the evaluation of an obesity related policy and /or program offers an uncommon and scientifically compelling research opportunity that will only be available if the research is initiated with minimum delay. For these reasons, applications in response to this time-sensitive FOA are not eligible for re-submission. It is intended that eligible applications selected for funding will be awarded within 4 months of the application due date. However, administrative requirements and other unforeseen circumstances may delay issuance dates beyond that timeline.
This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs international scientific priority areas(http://www.drugabuse.gov/international/research-priorities). While the priorities will change from year to year, in FY15 priority areas include: linkages between HIV/AIDS and drug abuse; prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders); the neuroscience of marijuana and cannabinoids; and the effect of changes in laws and policies on marijuana and its impact. The NIH R03 activity code supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. The R03 activity code supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
This funding opportunity announcement (FOA), issued by the NIH Basic Behavioral & Social Science Opportunity Network (OppNet), invites applications for short-term mentored career enhancement (K18) awards in basic behavioral and social sciences research (b-BSSR). This funding mechanism will support development of research capability in b-BSSR, with specific emphasis on cross-training and establishing collaborations between researchers with expertise in animal models of basic behavioral and social processes and those studying similar or related processes in human subjects. Basic research using any non-human species or with human subjects in laboratory- or field-based settings is appropriate for this FOA. Eligible candidates for this K18 will be either: (a) scientists conducting b-BSSR in animal models who seek training in the study of similar or related behavioral or social processes in humans; or (b) investigators conducting b-BSSR in human subjects who seek training in the study of similar or related processes in animal models. Candidates may be at any rank or level of research/academic development beyond three years of postdoctoral experience.
This funding opportunity announcement (FOA) invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD). Research is sought that will characterize the extent to which basic behavioral and neural processes involved in decision-making are differentially impacted in normal aging and AD, investigate the influence of social factors on decision-making, and investigate the decision-making factors that render older adults (with or without cognitive impairment) vulnerable to financial exploitation and other forms of mistreatment and abuse.
The FOA also invites applications to apply basic research on the processes involved in decision-making to the design of decision-supportive interventions for midlife and older adults with and without AD. Specific opportunities include the development of decision-supportive interventions to leverage cognitive, emotional and motivational strengths of these populations; tools to assess decisional capacity; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wells, etc.).
This funding opportunity announcement (FOA) invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD). Research is sought that will characterize the extent to which basic behavioral and neural processes involved in decision-making are differentially impacted in normal aging and AD, investigate the influence of social factors on decision-making, and investigate the decision-making factors that render older adults (with or without cognitive impairment) vulnerable to financial exploitation and other forms of mistreatment and abuse.
The FOA also invites applications to apply basic research on the processes involved in decision-making to the design of decision-supportive interventions for midlife and older adults with and without AD. Specific opportunities include the development of decision-supportive interventions to leverage cognitive, emotional and motivational strengths of these populations; tools to assess decisional capacity; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wells, etc.).
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites center applications for the Learning Disabilities Research Centers Program, hereafter termed 'LDRCs'. The LDRCs will focus on generating new scientific knowledge to inform our understanding of learning disabilities (LDs) and comorbid conditions through synergistic, integrated, team-based transdisciplinary science. This funding opportunity announcement invites both foundational and translational, transdisciplinary research addressing the definition, classification, etiology, diagnosis, epidemiology, early identification, prevention-based approaches, and remediation of children, adolescents, or adults identified with or at risk for LDs in component oral language abilities, reading, written expression abilities, mathematics and relationships among these LDs and other disabilities and co-occurring or comorbid conditions. The P50 mechanism allows for richly integrative, multi-method approaches to examine research topics focusing on learning disabilities that are not feasible through standard research mechanisms. The LDRCs provide a unique platform to engage with external research and community members and provide career enhancing opportunities for early career investigators expanding their reach and impact.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites center applications for the Learning Disabilities Research Centers Program, hereafter termed 'LDRCs'. The LDRCs will focus on generating new scientific knowledge to inform our understanding of learning disabilities (LDs) and comorbid conditions through synergistic, integrated, team-based transdisciplinary science. This funding opportunity announcement invites both foundational and translational, transdisciplinary research addressing the definition, classification, etiology, diagnosis, epidemiology, early identification, prevention-based approaches, and remediation of children, adolescents, or adults identified with or at risk for LDs in component oral language abilities, reading, written expression abilities, mathematics and relationships among these LDs and other disabilities and co-occurring or comorbid conditions. The P50 mechanism allows for richly integrative, multi-method approaches to examine research topics focusing on learning disabilities that are not feasible through standard research mechanisms. The LDRCs provide a unique platform to engage with external research and community members and provide career enhancing opportunities for early career investigators expanding their reach and impact.
This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across development in rodents and non-human primates. The goal is to build a foundation for understanding how interactions within and among brain regions change over pre- and post-natal development, allowing for the emergence of cognitive, affective and social behaviors. To this end, projects supported will focus on neurodevelopmental trajectories in rodents or non-human primates and investigate questions using in vivo neural measures in awake, behaving animals. This FOA uses the R01 grant mechanism, whereas its companion funding opportunity seeks shorter, higher-risk R21 grant applications.
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is issuing a Disruption Opportunity (DO) Special Notice (SN) inviting submissions of innovative basic or applied research concepts in the technical domain of understanding group biases. This DO SN is issued under the Program Announcement for Disruptioneering, DARPA-PA-18-01. All proposals in response to the technical area(s) described herein will be submitted to DARPA-PA-18-01 and if selected, will result in an award of an Other Transaction (OT) for prototype project not to exceed $1,000,000.
This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDA's international scientific priority areas (http://www.drugabuse.gov/international/research-priorities). While the priorities will change from year to year, in FY15 priority areas include: linkages between HIV/AIDS and drug abuse; prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders); the neuroscience of marijuana and cannabinoids; and the effect of changes in laws and policies on marijuana and its impact.
This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDA's international scientific priority areas (http://www.drugabuse.gov/international/research-priorities). While the priorities will change from year to year, in FY15 priority areas include: linkages between HIV/AIDS and drug abuse; prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders); the neuroscience of marijuana and cannabinoids; and the effect of changes in laws and policies on marijuana and its impact.
This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.
The complexities of brain and behavior pose fundamental questions in many areas of science and engineering, drawing intense interest across a broad spectrum of disciplinary perspectives while eluding explanation by any one of them. Rapid advances within and across disciplines are leading to an increasingly interconnected fabric of theories, models, empirical methods and findings, and educational approaches, opening new opportunities to understand complex aspects of neural and cognitive systems through integrative multidisciplinary approaches. This program calls for innovative, integrative, boundary-crossing proposals that can best capture those opportunities. NSF seeks proposals that are bold, risky, and transcend the perspectives and approaches typical of single-discipline research efforts
Eligible applicants are: 1) State and Territorial governments: Title V Agencies in states that have completed a Project LAUNCH grant, or will complete the grant by September 30, 2015. See Appendix II of the RFA for a listing of eligible applicants. 2) Federally recognized American Indian/Alaska Native (AI/AN) tribes and tribal organizations that have completed a Project LAUNCH grant, or will complete the grant by September 30, 2015. See Appendix II of the RFA for a listing of eligible applicants. Tribal organization means the recognized body of any AI/AN tribe; any legally established organization of American Indians/Alaska Natives which is controlled, sanctioned, or chartered by such governing body or which is democratically elected by the adult members of the Indian community to be served by such organization and which includes the maximum participation of American Indians/Alaska Natives in all phases of its activities. Eligibility is limited to State Title V Agencies, in states who have completed or will complete a Project LAUNCH grant by the end of FY 2015, since these are the agencies that received the initial Project LAUNCH grants. Project LAUNCH Expansion grants will build on the knowledge, expertise and experience acquired in the first Project LAUNCH grant in order to take practices and systems changes to scale by expanding these practices to other communities within the state/tribe (or to additional tribes). The Project LAUNCH Expansion grants will provide states and tribes the opportunity for broader dissemination of these innovative practices and policies that will lead to better outcomes for young children and families. In addition, the Title V agency was the convener of the original LAUNCH Council, and will be well-positioned to continue the work of increasing cross-agency and public-private partnerships through the Expansion grant. State Title V agencies should partner with the lead children's mental health agency as this grant opportunity is focused
This cooperative agreement will establish and maintain an interdisciplinary, multicenter research forum for scientific collaboration and infrastructure building, which will provide national leadership in research designed to improve the behavioral, mental, social, and/or cognitive health and wellbeing of children and adolescents with Autism Spectrum Disorder (ASD) and other developmental disabilities. As authorized by Section 399BB of the Autism CARES Act, the research network will determine the evidence-based practices for interventions to improve the behavioral health of individuals with ASD and other developmental disabilities, develop guidelines for those interventions, and disseminate information related to such research and guidelines. The AIR-B Network will be one of two HRSA-supported research networks that will provide national leadership in research to advance the evidence base on effective interventions for children and adolescents with ASD and other developmental disabilities, with AIR-B having a focus on addressing behavioral health and wellbeing. As directed by the FY 2015 Congressional Appropriations for HRSA's Autism CARES Act programs, HRSA is broadening the scope of this funding opportunity to reflect an additional emphasis on addressing disparities in effective interventions and treatment and access to care experienced by underserved minority and rural communities. In particular, applicants should consider diverse ethnic/racial, cultural, linguistic, socioeconomic, and geographic (e.g., rural/urban, tribal) populations for whom there is little evidence regarding the effectiveness of interventions, or for whom access to effective treatments is limited. Applicants should include plans to conduct multi-site research protocols on innovative treatment models, including the use of telehealth networks, to improve behavioral health interventions and treatment for ASD in underserved minority and rural communities. It is expected that the AIR-B Netwo
This initiative is funded through the NIH Common Fund, which supports cross-cutting programs that are expected to have exceptionally high impact. All Common Fund initiatives invite investigators to develop bold, innovative, and often risky approaches to address problems that may seem intractable or to seize new opportunities that offer the potential for rapid progress. This Phased Innovation Awards Cooperative Agreement Funding Opportunity Announcement (FOA) solicits applications to support a collaborative research infrastructure involving an interdisciplinary team of basic and clinical scientists to develop the foundation for an experimental medicine approach to behavior change. Research supported by this FOA is meant to support activities focused on behavior change targets in the domain of interpersonal and social processes through four main target validation steps: 1. Identify a set of putative targets within the interpersonal and social processes domain that are implicated in medical regimen adherence and at least one other health behavior; 2. Leverage existing or develop new experimental or intervention approaches to engage identified targets; 3. Identify or develop appropriate assays (measures) to permit verification of target engagement; 4. Test the degree to which engaging identified targets produces a desired change in medical regimen adherence and at least one other health behavior. While testing target engagement in specific clinical samples is permitted, the targets identified and the behavior change outcomes measured should be selected based on their hypothesized relevance to at least two clinical endpoints or disease conditions. Funds from the NIH will be made available through the UH2/UH3 Phased Innovation Awards Cooperative Agreement mechanism.The initial UH2 phase will support steps 1-3 above. UH2 projects that have met their objectives and agreed upon milestones will be administratively considered by NIH and prioritized for transition to the UH3 va
This initiative is funded through the NIH Common Fund, which supports cross-cutting programs that are expected to have exceptionally high impact. All Common Fund initiatives invite investigators to develop bold, innovative, and often risky approaches to address problems that may seem intractable or to seize new opportunities that offer the potential for rapid progress. This U24 Cooperative Agreement Funding Opportunity Announcement (FOA) will support the NIH Science of Behavior Change (SOBC) Resource and Coordinating Center (RCC), which will coordinate the activities of between five and nine UH2/UH3 Target Validation Projects. The initial UH2/UH3 awards will be made in response to three companion FOAs (RFA-RM-14-018, RFA-RM-14-019, RFA-RM-14-020) that will focus on identifying and validating targets in the three specific behavioral domains of self-regulation, stress reactivity and stress resilience, and interpersonal and social processes. The overall goal of the SOBC Program is to transform behavioral intervention designs by implementing the experimental medicine approach to behavior change research. The overall goal of the RCC will be to provide national leadership for the coordinated efforts of projects and initiatives of SOBC to validate assays for behavior change, with five specific objectives described in this FOA. The RCC will also serve as the central resource for the organization of the meetings and other activities of the SOBC program, including the support of its Steering Committee and External Scientific Panel, and any SOBC steering committee subcommittees that are established. Please refer to the SOBC website regularly for updates, frequently asked questions (FAQs), and other announcements related to this FOA and the companion FOAs. SOBC Website: http://www.commonfund.nih.gov/behaviorchange/ FAQs: http://www.commonfund.nih.gov/behaviorchange/faq/
The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (XXXX).
This Funding Opportunity Announcement (FOA) invites applications to provide infrastructure support for advancing development of specific high priority areas of behavioral and social research of relevance to aging. The infrastructure support will facilitate research networks through meetings, conferences, small scale pilots, short term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and build resources for advancing aging-relevant research in the field at large. Network applications are limited to the following areas: (1) Midlife Reversibility of Biobehavioral Risk associated with Early Life Adversity, (2) Stress Measurement, (3) Reproducibility in the Social and Behavioral Sciences, (4) Life Course Health Disparities at Older Ages, (5) Genomics of Behavioral and Social Science (6) Integrating Animal Models to Inform Behavioral and Social Research on Aging, and (7) Rural Aging.